MoH, Singapore’s Health Sciences Authority sign MoU to facilitate pharmaceutical regulatory information exchange

2 months ago 88

The re-signing of a memorandum of understanding between the Ministry of Health and the Health Sciences Authority of Singapore facilitates the process of exchanging pharmaceutical regulatory information between the two agencies to empower Good Regulatory Practice and at the same time improves efficiency. — Picture by Shafwan Zaidon

Join us on our WhatsApp Channel, follow us on Instagram, and receive browser alerts for the latest news you need to know.

Monday, 06 May 2024 8:20 PM MYT

PUTRAJAYA, May 6 — The re-signing of a memorandum of understanding (MoU) between the Ministry of Health (MoH) and the Health Sciences Authority (HSA) of Singapore facilitates the process of exchanging pharmaceutical regulatory information between the two agencies to empower Good Regulatory Practice and at the same time improves efficiency.

The Ministry of Health in a statement today said that among the areas of cooperation that have been identified and will continue is the regulatory control of pharmaceutical products including registration, post-registration and enforcement issues as well as clinical research activities.

According to MoH, the signing of cooperation between MoH and HSA is seen as a catalyst to increasing the efficiency of regulatory control of pharmaceutical products in Malaysia.

Advertisement

MoH said the MoU was originally signed on March 28...

Read Entire Article